Exercise capacity impairment in COPD patients with comorbidities

被引:6
作者
Da Silva, G. P. F. [1 ,3 ]
Pessoa Morano, M. T. A. [2 ]
De Matos Cavalcante, A. G. [1 ]
De Andrade, N. M. [1 ]
De Francesco Daher, E. [1 ]
Pereira, E. D. B. [1 ]
机构
[1] Univ Fed Ceara UFC, Fortaleza, Ceara, Brazil
[2] Hosp Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil
[3] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil
关键词
Exercise capacity; Health status; COPD; Comorbidity; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ARTERIAL STIFFNESS; EMPHYSEMA; MORTALITY; ANXIETY; IMPACT; INTERVENTION;
D O I
10.1016/j.rppnen.2015.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity. Objective: to evaluate the impact of comorbidities on functional capacity of COPD patients. Methods: a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having "none", "one" and "two or three'' comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT. Results: Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 +/- 8 years and 55% were male. CAT scores increased from "no comorbidity" (17.9 +/- 7.7) to "one comorbidity" (22.8 +/- 6.8) and "two or three comorbidities" groups (24.2 +/- 10.2). A post hoc test showed a significant difference in the "no comorbidity" compared to the "two or three comorbidities" groups (p = 0.01). The distance walked by the patients decreased from "no comorbidity" (386.1 +/- 83.2 m) to "one comorbidity" (350 +/- 98 m) and "two or three comorbidities" groups (312.6 +/- 91 m). A post hoc test showed significant difference in the "no comorbidity" compared to "two or three comorbidities" groups (p = 0.007). Numbers of comorbidities were independently associated with the 6 MWT adjusting for age, severity of COPD and CAT scores. Conclusion: in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD. (C) 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 33 条
[1]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[2]   Impact of comorbidities on COPD-specific health-related quality of life [J].
Burgel, Pierre-Regis ;
Escamilla, Roger ;
Perez, Thierry ;
Carre, Philippe ;
Caillaud, Denis ;
Chanez, Pascal ;
Pinet, Christophe ;
Jebrakh, Gilles ;
Brinchault, Graziella ;
Court-Fortune, Isabelle ;
Paillasseur, Jean-Louis ;
Roche, Nicolas .
RESPIRATORY MEDICINE, 2013, 107 (02) :233-241
[3]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[4]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[5]   Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation [J].
Crisafulli, E. ;
Costi, S. ;
Luppi, F. ;
Cirelli, G. ;
Cilione, C. ;
Coletti, O. ;
Fabbri, L. M. ;
Clini, E. M. .
THORAX, 2008, 63 (06) :487-492
[6]   Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression [J].
Cully, Jeffrey A. ;
Graham, David P. ;
Stanley, Melinda A. ;
Ferguson, Chris J. ;
Sharafkhaneh, Amir ;
Souchek, Julianne ;
Kunik, Mark E. .
PSYCHOSOMATICS, 2006, 47 (04) :312-319
[7]   Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients [J].
Curkendall, SM ;
DeLuise, C ;
Jones, JK ;
Lanes, S ;
Stang, MR ;
Goehring, E ;
She, DW .
ANNALS OF EPIDEMIOLOGY, 2006, 16 (01) :63-70
[8]   Comparison of face-to-face interview and telephone interview administration of COPD assessment test: a randomized study [J].
da Silva, Guilherme F. ;
Morano, Maria Tereza A. ;
Sales, Maria Penha U. ;
Olegario, Natalia B. ;
Cavalcante, Antonio George M. ;
Pereira, Eanes D. B. .
QUALITY OF LIFE RESEARCH, 2014, 23 (04) :1193-1197
[9]  
Dal Negro Roberto, 2008, Int J Chron Obstruct Pulmon Dis, V3, P1
[10]   COPD as a Lung Disease with Systemic Consequences - Clinical Impact, Mechanisms, and Potential for Early Intervention [J].
Decramer, Marc ;
Rennard, Stephen ;
Troosters, Thierry ;
Mapel, Douglas W. ;
Giardino, Nicholas ;
Mannino, David ;
Wouters, Emiel ;
Sethi, Sanjay ;
Cooper, Christopher B. .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (04) :235-256